Halozyme Therapeutics HALO Gross margin

Gross margin at other companies

West Pharmaceutical ServicesWST

36.8%+1.5pp

AMP

Amphastar PharmaceuticalsAMPH

47.7%-2.2pp

AptarGroupATR

36.7%-1.6pp

Opko HealthOPK

40.8%+8.1pp

Amneal Pharmaceuticals, Inc.AMRX

39.3%+1.7pp

Aquestive Therapeutics, Inc.AQST

63.5%-4.9pp

FAQ

What is Halozyme Therapeutics's gross margin?

Halozyme Therapeutics (HALO) reported gross margin of 82.4% in Q2 2026.

How has Halozyme Therapeutics's gross margin changed year-over-year?

Halozyme Therapeutics's gross margin decreased by 2.1% year-over-year, from 84.2% to 82.4%.

What is the long-term trend for Halozyme Therapeutics's gross margin?

Over 5 years (2020 to 2025), Halozyme Therapeutics's gross margin has grown at a -0.0% compound annual growth rate (CAGR), from 83.8% to 83.6%.

What does gross margin mean?

Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.